# Coursera timeline

entity: /record/coursera.md  
id: ent_coursera  


## undated

- undated | fiscal_year_end | 12-31 | valid | [clm_2728CE2E8895](/claim/clm_2728CE2E8895.md)
- undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_50F860875207](/claim/clm_50F860875207.md)
- undated | state_of_incorporation | DE | valid | [clm_5DBF2D8F9BF0](/claim/clm_5DBF2D8F9BF0.md)
- undated | ticker | COUR | valid | [clm_60450AB68EF9](/claim/clm_60450AB68EF9.md)
- undated | registrant_name | Coursera, Inc. | valid | [clm_66B338E78EC9](/claim/clm_66B338E78EC9.md)
- undated | listed_on | NYSE | valid | [clm_A27BB734390F](/claim/clm_A27BB734390F.md)
- undated | cik | 0001651562 | valid | [clm_E4A4C68CABBC](/claim/clm_E4A4C68CABBC.md)

## 2011

- 2011-08-09 | x_username | coursera | unverified | [clm_466DA3631452](/claim/clm_466DA3631452.md)

## undated

- undated | listed_on | New York Stock Exchange | unverified | [clm_36458DA68851](/claim/clm_36458DA68851.md)
- undated | industry | educational technology | unverified | [clm_5D837DDCFCC1](/claim/clm_5D837DDCFCC1.md)
- undated | founder | Andrew Y. Ng | valid | [clm_7A4AAC57BD07](/claim/clm_7A4AAC57BD07.md)
- undated | country | United States | unverified | [clm_898908D60F69](/claim/clm_898908D60F69.md)

## 2012

- 2012-01-01 | founded | 2012-01-01 | unverified | [clm_B6F11CEF2364](/claim/clm_B6F11CEF2364.md)

## undated

- undated | founder | Daphne Koller | valid | [clm_DE48EE963DFF](/claim/clm_DE48EE963DFF.md)
- undated | legal_form | Delaware corporation | unverified | [clm_E5CCB455C7C5](/claim/clm_E5CCB455C7C5.md)
- undated | headquarters | Mountain View | unverified | [clm_F1CA97E5F5B3](/claim/clm_F1CA97E5F5B3.md)
- undated | website | https://www.coursera.org | unverified | [clm_F3E0C1EEA9A9](/claim/clm_F3E0C1EEA9A9.md)

## 2017

- 2017-01-01 to 2025-02-03 | ceo | Jeff Maggioncalda | superseded | [clm_18E75BCFC24F](/claim/clm_18E75BCFC24F.md)

## 2018

- 2018-12-31 to 2019-12-31 | total_equity | -177,735,000 United States dollar | superseded | [clm_C775119B2C34](/claim/clm_C775119B2C34.md)

## 2019

- 2019-12-31 to 2020-12-31 | operating_income | -48,394,000 United States dollar | superseded | [clm_5C102FD164F4](/claim/clm_5C102FD164F4.md)
- 2019-12-31 to 2020-12-31 | revenue | 184,411,000 United States dollar | superseded | [clm_7FF836157D19](/claim/clm_7FF836157D19.md)
- 2019-12-31 to 2020-12-31 | net_income | -46,719,000 United States dollar | superseded | [clm_8E3FEC7C598C](/claim/clm_8E3FEC7C598C.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 56,364,000 United States dollar | superseded | [clm_EA578940E6B3](/claim/clm_EA578940E6B3.md)
- 2019-12-31 to 2020-03-31 | total_equity | -186,999,000 United States dollar | superseded | [clm_F14BA1DE0E04](/claim/clm_F14BA1DE0E04.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 55,986,000 United States dollar | superseded | [clm_F561F729156D](/claim/clm_F561F729156D.md)

## 2020

- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 103,935,000 United States dollar | superseded | [clm_1A7B31F0259B](/claim/clm_1A7B31F0259B.md)
- 2020-03-31 to 2020-06-30 | total_equity | -197,694,000 United States dollar | superseded | [clm_54B9EF785871](/claim/clm_54B9EF785871.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | -14,314,000 United States dollar | superseded | [clm_9F1BB416D58F](/claim/clm_9F1BB416D58F.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 15,783,000 United States dollar | superseded | [clm_B70DE4122CB3](/claim/clm_B70DE4122CB3.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | -14,669,000 United States dollar | superseded | [clm_B8CD2159A849](/claim/clm_B8CD2159A849.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 53,847,000 United States dollar | superseded | [clm_D4276F715B43](/claim/clm_D4276F715B43.md)
- 2020-06-30 to 2020-09-30 | total_equity | -206,192,000 United States dollar | superseded | [clm_0EA7C7B9F3EE](/claim/clm_0EA7C7B9F3EE.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 73,728,000 United States dollar | superseded | [clm_2491E7C4F029](/claim/clm_2491E7C4F029.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 119,354,000 United States dollar | superseded | [clm_27A838765E1A](/claim/clm_27A838765E1A.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 18,046,000 United States dollar | superseded | [clm_2869682CB994](/claim/clm_2869682CB994.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | -13,916,000 United States dollar | superseded | [clm_5068CE700AFD](/claim/clm_5068CE700AFD.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | -13,836,000 United States dollar | superseded | [clm_E0E8DA4FE05A](/claim/clm_E0E8DA4FE05A.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | -11,867,000 United States dollar | superseded | [clm_4B096D2A602E](/claim/clm_4B096D2A602E.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 82,674,000 United States dollar | superseded | [clm_4FECE931CE48](/claim/clm_4FECE931CE48.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | -11,888,000 United States dollar | superseded | [clm_5B1400AEF386](/claim/clm_5B1400AEF386.md)
- 2020-09-30 to 2020-12-31 | total_equity | -208,248,000 United States dollar | superseded | [clm_8146DD5F0664](/claim/clm_8146DD5F0664.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 19,620,000 United States dollar | superseded | [clm_D7E60C32923B](/claim/clm_D7E60C32923B.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 103,536,000 United States dollar | superseded | [clm_DB383241F940](/claim/clm_DB383241F940.md)
- 2020-12-31 to 2021-03-31 | total_equity | -221,824,000 United States dollar | superseded | [clm_0479FB2BEFEB](/claim/clm_0479FB2BEFEB.md)
- 2020-12-31 to 2021-12-31 | net_income | -66,815,000 United States dollar | superseded | [clm_14FD48EFFB71](/claim/clm_14FD48EFFB71.md)
- 2020-12-31 to 2021-03-31 | total_assets | 417,624,000 United States dollar | superseded | [clm_4B4C72D55832](/claim/clm_4B4C72D55832.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 79,878,000 United States dollar | superseded | [clm_58ECD11EAD23](/claim/clm_58ECD11EAD23.md)
- 2020-12-31 to 2021-12-31 | operating_income | -66,583,000 United States dollar | superseded | [clm_C4CBD7D54FF8](/claim/clm_C4CBD7D54FF8.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 76,784,000 United States dollar | superseded | [clm_E43D089348DA](/claim/clm_E43D089348DA.md)
- 2020-12-31 to 2021-12-31 | revenue | 293,511,000 United States dollar | superseded | [clm_E970EB8BD71C](/claim/clm_E970EB8BD71C.md)

## 2021

- 2021-03-31 to 2021-06-30 | total_assets | 414,822,000 United States dollar | superseded | [clm_05E9849CB730](/claim/clm_05E9849CB730.md)
- 2021-03-31 to 2021-06-30 | total_equity | -226,089,000 United States dollar | superseded | [clm_50A88A537EF5](/claim/clm_50A88A537EF5.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 88,362,000 United States dollar | superseded | [clm_6AB09D5F0394](/claim/clm_6AB09D5F0394.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | -18,361,000 United States dollar | superseded | [clm_72DCAB4467F6](/claim/clm_72DCAB4467F6.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 22,140,000 United States dollar | superseded | [clm_7990AE480358](/claim/clm_7990AE480358.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 158,072,000 United States dollar | superseded | [clm_E59AC0CB617D](/claim/clm_E59AC0CB617D.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | -18,663,000 United States dollar | superseded | [clm_EE2E17BB4D0D](/claim/clm_EE2E17BB4D0D.md)
- 2021-04-30 to 2021-07-31 | shares_outstanding | 135,770,469 shares | superseded | [clm_F6EB9A271A42](/claim/clm_F6EB9A271A42.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 749,649,000 United States dollar | superseded | [clm_7849F58F921C](/claim/clm_7849F58F921C.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 41,004,000 United States dollar | superseded | [clm_82CC83911779](/claim/clm_82CC83911779.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | -45,785,000 United States dollar | superseded | [clm_AD01CD4F52E9](/claim/clm_AD01CD4F52E9.md)
- 2021-06-30 to 2021-09-30 | total_equity | 755,409,000 United States dollar | superseded | [clm_CD8F5F5E7FE8](/claim/clm_CD8F5F5E7FE8.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | -46,363,000 United States dollar | superseded | [clm_DFC426A47C6F](/claim/clm_DFC426A47C6F.md)
- 2021-06-30 to 2021-09-30 | total_assets | 953,580,000 United States dollar | superseded | [clm_E03C6D6C61CB](/claim/clm_E03C6D6C61CB.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 102,089,000 United States dollar | superseded | [clm_E0DF2607825E](/claim/clm_E0DF2607825E.md)
- 2021-07-31 to 2021-10-31 | shares_outstanding | 137,743,251 shares | superseded | [clm_A7A7608D36A6](/claim/clm_A7A7608D36A6.md)
- 2021-09-30 to 2021-12-31 | total_assets | 954,849,000 United States dollar | superseded | [clm_14F5314D7978](/claim/clm_14F5314D7978.md)
- 2021-09-30 to 2021-12-31 | total_equity | 755,978,000 United States dollar | superseded | [clm_24525395156C](/claim/clm_24525395156C.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 109,880,000 United States dollar | superseded | [clm_4687216701B8](/claim/clm_4687216701B8.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 801,074,000 United States dollar | superseded | [clm_77415382D19C](/claim/clm_77415382D19C.md)
- 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 33,935,000 United States dollar | superseded | [clm_9D9ED2142414](/claim/clm_9D9ED2142414.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | -31,427,000 United States dollar | superseded | [clm_A2A57CFD2B60](/claim/clm_A2A57CFD2B60.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | -32,451,000 United States dollar | superseded | [clm_BE0577E2FD57](/claim/clm_BE0577E2FD57.md)
- 2021-10-31 to 2022-02-24 | shares_outstanding | 140,589,748 shares | superseded | [clm_2F0C8C7E2B41](/claim/clm_2F0C8C7E2B41.md)
- 2021-12-31 to 2022-12-31 | revenue | 415,287,000 United States dollar | superseded | [clm_1E3CC87C6D7E](/claim/clm_1E3CC87C6D7E.md)
- 2021-12-31 to 2022-03-31 | total_equity | 741,513,000 United States dollar | superseded | [clm_40C8CBB87EBB](/claim/clm_40C8CBB87EBB.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 135,410,000 United States dollar | superseded | [clm_4B96885695EE](/claim/clm_4B96885695EE.md)
- 2021-12-31 to 2022-12-31 | operating_income | -143,063,000 United States dollar | superseded | [clm_56659D23BD7B](/claim/clm_56659D23BD7B.md)
- 2021-12-31 to 2022-12-31 | net_income | -145,215,000 United States dollar | superseded | [clm_9CEB464D6B97](/claim/clm_9CEB464D6B97.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 580,658,000 United States dollar | superseded | [clm_CCF7D8E0F4C1](/claim/clm_CCF7D8E0F4C1.md)
- 2021-12-31 to 2022-03-31 | total_assets | 958,910,000 United States dollar | superseded | [clm_D7A9C2F9EEC8](/claim/clm_D7A9C2F9EEC8.md)

## 2022

- 2022-02-24 to 2022-04-28 | shares_outstanding | 143,301,257 shares | superseded | [clm_7B5BD4B3305E](/claim/clm_7B5BD4B3305E.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 37,955,000 United States dollar | superseded | [clm_2045779655C3](/claim/clm_2045779655C3.md)
- 2022-03-31 to 2022-06-30 | total_assets | 946,864,000 United States dollar | superseded | [clm_25616AA0AA26](/claim/clm_25616AA0AA26.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | -37,170,000 United States dollar | superseded | [clm_30F58A5A81A9](/claim/clm_30F58A5A81A9.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 361,315,000 United States dollar | superseded | [clm_3B424E1DD5A5](/claim/clm_3B424E1DD5A5.md)
- 2022-03-31 to 2022-06-30 | total_equity | 728,685,000 United States dollar | superseded | [clm_AEABC65DBBF9](/claim/clm_AEABC65DBBF9.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | -38,268,000 United States dollar | superseded | [clm_B9C7EFC88FE0](/claim/clm_B9C7EFC88FE0.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 120,433,000 United States dollar | superseded | [clm_DB84FDD65E6D](/claim/clm_DB84FDD65E6D.md)
- 2022-04-28 to 2022-07-28 | shares_outstanding | 144,051,175 shares | superseded | [clm_9C6D71FF23A8](/claim/clm_9C6D71FF23A8.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | -49,334,000 United States dollar | superseded | [clm_1664F7BF5EA8](/claim/clm_1664F7BF5EA8.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 44,929,000 United States dollar | superseded | [clm_181670DA3BD6](/claim/clm_181670DA3BD6.md)
- 2022-06-30 to 2022-09-30 | total_equity | 715,787,000 United States dollar | superseded | [clm_2812948B08A5](/claim/clm_2812948B08A5.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 380,005,000 United States dollar | superseded | [clm_7E922BC44C3F](/claim/clm_7E922BC44C3F.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | -47,835,000 United States dollar | superseded | [clm_91F28BA7B4D6](/claim/clm_91F28BA7B4D6.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 124,754,000 United States dollar | superseded | [clm_E685D9D6E487](/claim/clm_E685D9D6E487.md)
- 2022-06-30 to 2022-09-30 | total_assets | 952,390,000 United States dollar | superseded | [clm_E8BA4FC8E993](/claim/clm_E8BA4FC8E993.md)
- 2022-07-28 to 2022-10-28 | shares_outstanding | 145,763,241 shares | superseded | [clm_FC3E780508C9](/claim/clm_FC3E780508C9.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | -36,349,000 United States dollar | superseded | [clm_0AE6E21FBE3C](/claim/clm_0AE6E21FBE3C.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 424,796,000 United States dollar | superseded | [clm_322978A1D0C9](/claim/clm_322978A1D0C9.md)
- 2022-09-30 to 2022-12-31 | total_assets | 956,256,000 United States dollar | superseded | [clm_588386DA5CF6](/claim/clm_588386DA5CF6.md)
- 2022-09-30 to 2022-12-31 | total_equity | 708,981,000 United States dollar | superseded | [clm_7F7B59BF5227](/claim/clm_7F7B59BF5227.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 136,389,000 United States dollar | superseded | [clm_895BF7279843](/claim/clm_895BF7279843.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 39,415,000 United States dollar | superseded | [clm_96C2FA01F081](/claim/clm_96C2FA01F081.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | -36,038,000 United States dollar | superseded | [clm_E59DAB210402](/claim/clm_E59DAB210402.md)
- 2022-10-28 to 2023-02-16 | shares_outstanding | 146,580,369 shares | superseded | [clm_D535A031A9A3](/claim/clm_D535A031A9A3.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 165,134,000 United States dollar | superseded | [clm_0927A6AC4928](/claim/clm_0927A6AC4928.md)
- 2022-12-31 to 2023-12-31 | revenue | 523,756,000 United States dollar | superseded | [clm_303EB36FE412](/claim/clm_303EB36FE412.md)
- 2022-12-31 to 2023-03-31 | total_assets | 947,597,000 United States dollar | superseded | [clm_39DED5C9214E](/claim/clm_39DED5C9214E.md)
- 2022-12-31 to 2023-03-31 | total_equity | 694,575,000 United States dollar | superseded | [clm_86BD6F80B0EB](/claim/clm_86BD6F80B0EB.md)
- 2022-12-31 to 2023-12-31 | net_income | -175,357,000 United States dollar | superseded | [clm_9D0924ADC4A8](/claim/clm_9D0924ADC4A8.md)
- 2022-12-31 to 2023-12-31 | operating_income | -177,380,000 United States dollar | superseded | [clm_A7703D79E0D6](/claim/clm_A7703D79E0D6.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 320,817,000 United States dollar | superseded | [clm_E86C874F3325](/claim/clm_E86C874F3325.md)

## 2023

- 2023-01-04 | board_member | Christopher D. McCarthy | valid | [clm_B2E88AB5CE88](/claim/clm_B2E88AB5CE88.md)
- 2023-02-16 to 2023-04-27 | shares_outstanding | 149,649,901 shares | superseded | [clm_3469FEABF87B](/claim/clm_3469FEABF87B.md)
- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 43,809,000 United States dollar | superseded | [clm_63B4D07A4F78](/claim/clm_63B4D07A4F78.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 267,774,000 United States dollar | superseded | [clm_83A009985639](/claim/clm_83A009985639.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 147,642,000 United States dollar | superseded | [clm_BCB6106F649E](/claim/clm_BCB6106F649E.md)
- 2023-03-31 to 2023-06-30 | total_equity | 681,015,000 United States dollar | superseded | [clm_C140B1ED6740](/claim/clm_C140B1ED6740.md)
- 2023-03-31 to 2023-06-30 | total_assets | 964,055,000 United States dollar | superseded | [clm_CFAE2CA8A4DF](/claim/clm_CFAE2CA8A4DF.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | -39,077,000 United States dollar | superseded | [clm_DDCD75E1FE09](/claim/clm_DDCD75E1FE09.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | -32,364,000 United States dollar | superseded | [clm_E7200705F7A4](/claim/clm_E7200705F7A4.md)
- 2023-04-27 to 2023-07-27 | shares_outstanding | 150,719,433 shares | superseded | [clm_42DE89561371](/claim/clm_42DE89561371.md)
- 2023-06-30 to 2023-09-30 | total_equity | 626,481,000 United States dollar | superseded | [clm_319BCD58886F](/claim/clm_319BCD58886F.md)
- 2023-06-30 to 2023-09-30 | total_assets | 918,710,000 United States dollar | superseded | [clm_59F061160943](/claim/clm_59F061160943.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 153,702,000 United States dollar | superseded | [clm_67CAE96C4C06](/claim/clm_67CAE96C4C06.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | -31,743,000 United States dollar | superseded | [clm_8AE35644FB42](/claim/clm_8AE35644FB42.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | -38,376,000 United States dollar | superseded | [clm_A9EBBEEBF4E3](/claim/clm_A9EBBEEBF4E3.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 361,201,000 United States dollar | superseded | [clm_ACC61065522D](/claim/clm_ACC61065522D.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 41,286,000 United States dollar | superseded | [clm_D08DB49A0569](/claim/clm_D08DB49A0569.md)
- 2023-07-27 to 2023-10-26 | shares_outstanding | 149,691,192 shares | superseded | [clm_F2C59741A4FE](/claim/clm_F2C59741A4FE.md)
- 2023-08-18 | board_member | Susan W. Muigai | valid | [clm_F7D974BB7405](/claim/clm_F7D974BB7405.md)
- 2023-09-30 to 2023-12-31 | total_assets | 914,345,000 United States dollar | superseded | [clm_2A4BF53E9013](/claim/clm_2A4BF53E9013.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 37,616,000 United States dollar | superseded | [clm_3D459D73DBB0](/claim/clm_3D459D73DBB0.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | -32,090,000 United States dollar | superseded | [clm_47643B676A03](/claim/clm_47643B676A03.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | -39,584,000 United States dollar | superseded | [clm_8EF14B6CD8C0](/claim/clm_8EF14B6CD8C0.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 507,157,000 United States dollar | superseded | [clm_B4FBFD218DBB](/claim/clm_B4FBFD218DBB.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 165,540,000 United States dollar | superseded | [clm_D170CCA9569E](/claim/clm_D170CCA9569E.md)
- 2023-09-30 to 2023-12-31 | total_equity | 613,401,000 United States dollar | superseded | [clm_EC9621890D5E](/claim/clm_EC9621890D5E.md)
- 2023-10-26 to 2024-02-15 | shares_outstanding | 152,547,664 shares | superseded | [clm_6E22933D0EBA](/claim/clm_6E22933D0EBA.md)
- 2023-12-31 to 2024-12-31 | revenue | 635,764,000 United States dollar | superseded | [clm_1F0E6F29AB8F](/claim/clm_1F0E6F29AB8F.md)
- 2023-12-31 to 2024-03-31 | total_equity | 616,194,000 United States dollar | superseded | [clm_215A745C79B9](/claim/clm_215A745C79B9.md)
- 2023-12-31 to 2024-12-31 | net_income | -116,554,000 United States dollar | superseded | [clm_36DF6C3005E9](/claim/clm_36DF6C3005E9.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 656,321,000 United States dollar | superseded | [clm_84CDEE0CC81B](/claim/clm_84CDEE0CC81B.md)
- 2023-12-31 to 2024-12-31 | operating_income | -145,596,000 United States dollar | superseded | [clm_9880E6B52931](/claim/clm_9880E6B52931.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 160,077,000 United States dollar | superseded | [clm_E9866B619E31](/claim/clm_E9866B619E31.md)
- 2023-12-31 to 2024-03-31 | total_assets | 920,533,000 United States dollar | superseded | [clm_FBBDC3E250CF](/claim/clm_FBBDC3E250CF.md)

## 2024

- 2024-02-15 to 2024-04-25 | shares_outstanding | 156,946,046 shares | superseded | [clm_3CAB1D6CABC8](/claim/clm_3CAB1D6CABC8.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 34,610,000 United States dollar | superseded | [clm_14E27735CE88](/claim/clm_14E27735CE88.md)
- 2024-03-31 to 2024-06-30 | total_assets | 916,303,000 United States dollar | superseded | [clm_2F68F3DE35AF](/claim/clm_2F68F3DE35AF.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | -21,256,000 United States dollar | superseded | [clm_374D621589F9](/claim/clm_374D621589F9.md)
- 2024-03-31 to 2024-06-30 | total_equity | 609,114,000 United States dollar | superseded | [clm_8216139C34CA](/claim/clm_8216139C34CA.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | -29,742,000 United States dollar | superseded | [clm_A67C94102E9C](/claim/clm_A67C94102E9C.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 169,068,000 United States dollar | superseded | [clm_F3D0F27E801E](/claim/clm_F3D0F27E801E.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 725,363,000 United States dollar | superseded | [clm_F6F2B6D86EF7](/claim/clm_F6F2B6D86EF7.md)
- 2024-04-25 to 2024-07-25 | shares_outstanding | 156,111,926 shares | superseded | [clm_4DEE3427AD92](/claim/clm_4DEE3427AD92.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 708,761,000 United States dollar | superseded | [clm_0AD056590D5F](/claim/clm_0AD056590D5F.md)
- 2024-06-30 to 2024-09-30 | total_assets | 904,364,000 United States dollar | superseded | [clm_4596C9F22428](/claim/clm_4596C9F22428.md)
- 2024-06-30 to 2024-09-30 | total_equity | 585,174,000 United States dollar | superseded | [clm_845BA5BFDA5E](/claim/clm_845BA5BFDA5E.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 33,701,000 United States dollar | superseded | [clm_87EA7212809F](/claim/clm_87EA7212809F.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | -22,974,000 United States dollar | superseded | [clm_ABEA28A15401](/claim/clm_ABEA28A15401.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | -31,209,000 United States dollar | superseded | [clm_C4C56E15297B](/claim/clm_C4C56E15297B.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 170,337,000 United States dollar | superseded | [clm_DC7957305D4C](/claim/clm_DC7957305D4C.md)
- 2024-07-25 to 2024-10-31 | shares_outstanding | 156,916,076 shares | superseded | [clm_AACB6A2D5492](/claim/clm_AACB6A2D5492.md)
- 2024-09-30 to 2024-12-31 | total_assets | 914,139,000 United States dollar | superseded | [clm_07A034FB97CF](/claim/clm_07A034FB97CF.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 31,615,000 United States dollar | superseded | [clm_11C68A7A4D9C](/claim/clm_11C68A7A4D9C.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | -21,770,000 United States dollar | superseded | [clm_1939DE7E2D4F](/claim/clm_1939DE7E2D4F.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 176,089,000 United States dollar | superseded | [clm_3E9D9C20249B](/claim/clm_3E9D9C20249B.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 719,439,000 United States dollar | superseded | [clm_9B58A2C65EFB](/claim/clm_9B58A2C65EFB.md)
- 2024-09-30 to 2024-12-31 | total_equity | 593,282,000 United States dollar | superseded | [clm_B4D17218C2ED](/claim/clm_B4D17218C2ED.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | -13,689,000 United States dollar | superseded | [clm_B9B1FA0A7A1B](/claim/clm_B9B1FA0A7A1B.md)
- 2024-10-31 to 2025-02-14 | shares_outstanding | 158,399,814 shares | superseded | [clm_0D85D807F1FF](/claim/clm_0D85D807F1FF.md)
- 2024-12-31 to 2025-12-31 | net_income | -79,530,000 United States dollar | superseded | [clm_3F09104E450D](/claim/clm_3F09104E450D.md)
- 2024-12-31 to 2025-03-31 | total_equity | 597,420,000 United States dollar | superseded | [clm_4CD3B276FA28](/claim/clm_4CD3B276FA28.md)
- 2024-12-31 to 2025-12-31 | operating_income | -113,219,000 United States dollar | superseded | [clm_B3B0FA924716](/claim/clm_B3B0FA924716.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 132,048,000 United States dollar | superseded | [clm_CA5719AB87C7](/claim/clm_CA5719AB87C7.md)
- 2024-12-31 to 2025-12-31 | revenue | 694,674,000 United States dollar | superseded | [clm_CB19ED375551](/claim/clm_CB19ED375551.md)
- 2024-12-31 to 2025-03-31 | total_assets | 930,274,000 United States dollar | superseded | [clm_D4CDB769B4D6](/claim/clm_D4CDB769B4D6.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 726,125,000 United States dollar | superseded | [clm_D4F091CD29ED](/claim/clm_D4F091CD29ED.md)

## 2025

- 2025-02-03 | ceo | Gregory Hart | valid | [clm_2B364A8601BC](/claim/clm_2B364A8601BC.md)
- 2025-02-03 | president | Gregory Hart | valid | [clm_4DE753B36E0D](/claim/clm_4DE753B36E0D.md)
- 2025-02-03 | board_member | Gregory Hart | valid | [clm_78416618C798](/claim/clm_78416618C798.md)
- 2025-02-14 to 2025-04-24 | shares_outstanding | 160,205,628 shares | superseded | [clm_43659E795A32](/claim/clm_43659E795A32.md)
- 2025-03-31 to 2025-06-30 | total_assets | 951,200,000 United States dollar | superseded | [clm_14C4709B5A9C](/claim/clm_14C4709B5A9C.md)
- 2025-03-31 to 2025-06-30 | total_equity | 610,500,000 United States dollar | superseded | [clm_41EECA90584D](/claim/clm_41EECA90584D.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | -14,400,000 United States dollar | superseded | [clm_84ACE18D566F](/claim/clm_84ACE18D566F.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 179,300,000 United States dollar | superseded | [clm_AC989FC7F377](/claim/clm_AC989FC7F377.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 748,000,000 United States dollar | superseded | [clm_B87B76DE929F](/claim/clm_B87B76DE929F.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | -7,800,000 United States dollar | superseded | [clm_D14E5BA6E088](/claim/clm_D14E5BA6E088.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 29,500,000 United States dollar | superseded | [clm_FB8A8EC9CD0E](/claim/clm_FB8A8EC9CD0E.md)
- 2025-04-24 to 2025-07-24 | shares_outstanding | 161,400,000 shares | superseded | [clm_D223096A2B52](/claim/clm_D223096A2B52.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 29,300,000 United States dollar | superseded | [clm_018F19D53EF0](/claim/clm_018F19D53EF0.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | -15,100,000 United States dollar | superseded | [clm_08BB66DA8327](/claim/clm_08BB66DA8327.md)
- 2025-06-30 to 2025-09-30 | total_equity | 627,000,000 United States dollar | superseded | [clm_8830038EA75B](/claim/clm_8830038EA75B.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 187,100,000 United States dollar | superseded | [clm_9C1B91DCB481](/claim/clm_9C1B91DCB481.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 775,100,000 United States dollar | superseded | [clm_B1F3744B1FEA](/claim/clm_B1F3744B1FEA.md)
- 2025-06-30 to 2025-09-30 | total_assets | 979,900,000 United States dollar | superseded | [clm_D3F5DD4212C3](/claim/clm_D3F5DD4212C3.md)
- 2025-07-24 to 2025-10-23 | shares_outstanding | 163,700,000 shares | superseded | [clm_A154ADA8163D](/claim/clm_A154ADA8163D.md)
- 2025-09-30 to 2025-12-31 | total_assets | 995,300,000 United States dollar | superseded | [clm_128684BFFF5D](/claim/clm_128684BFFF5D.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 194,200,000 United States dollar | superseded | [clm_4B456CBE41DC](/claim/clm_4B456CBE41DC.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | -8,600,000 United States dollar | superseded | [clm_645CE13B3354](/claim/clm_645CE13B3354.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 30,000,000 United States dollar | superseded | [clm_9BEDEBDDA605](/claim/clm_9BEDEBDDA605.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 797,700,000 United States dollar | superseded | [clm_9E95A22FFB33](/claim/clm_9E95A22FFB33.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | -15,600,000 United States dollar | superseded | [clm_ADA3E53045FB](/claim/clm_ADA3E53045FB.md)
- 2025-09-30 to 2025-12-31 | total_equity | 639,500,000 United States dollar | superseded | [clm_F266088E4CD8](/claim/clm_F266088E4CD8.md)
- 2025-10-23 to 2026-02-13 | shares_outstanding | 166,400,000 shares | superseded | [clm_9821E0911964](/claim/clm_9821E0911964.md)
- 2025-12-17 | agreement | Udemy, Inc. | valid | [clm_9D01C8D8E044](/claim/clm_9D01C8D8E044.md)
- 2025-12-31 | revenue | 757,500,000 United States dollar | valid | [clm_21BF0729F906](/claim/clm_21BF0729F906.md)
- 2025-12-31 | net_income | -51,000,000 United States dollar | valid | [clm_640F6B62B034](/claim/clm_640F6B62B034.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 792,600,000 United States dollar | superseded | [clm_8B39773BFF80](/claim/clm_8B39773BFF80.md)
- 2025-12-31 to 2026-03-31 | total_equity | 635,700,000 United States dollar | superseded | [clm_A74AE4CBD265](/claim/clm_A74AE4CBD265.md)
- 2025-12-31 | operating_income | -77,400,000 United States dollar | valid | [clm_C119ED472D27](/claim/clm_C119ED472D27.md)
- 2025-12-31 to 2026-03-31 | total_assets | 1,000,000,000 United States dollar | superseded | [clm_F26E49CA84D2](/claim/clm_F26E49CA84D2.md)
- 2025-12-31 | research_and_development | 121,600,000 United States dollar | valid | [clm_F8B584E639B8](/claim/clm_F8B584E639B8.md)

## 2026

- 2026-02-13 to 2026-04-23 | shares_outstanding | 168,200,000 shares | superseded | [clm_BF01EFA432D6](/claim/clm_BF01EFA432D6.md)
- 2026-03-16 | cfo | Michael Foley | valid | [clm_49CFAB8EE5AA](/claim/clm_49CFAB8EE5AA.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 789,800,000 United States dollar | superseded | [clm_0255FDC52331](/claim/clm_0255FDC52331.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | -20,500,000 United States dollar | superseded | [clm_1C31DF4095AF](/claim/clm_1C31DF4095AF.md)
- 2026-03-31 to 2026-06-30 | total_equity | 631,800,000 United States dollar | superseded | [clm_1E1ACC9A5C23](/claim/clm_1E1ACC9A5C23.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 31,300,000 United States dollar | superseded | [clm_2C2104369759](/claim/clm_2C2104369759.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 195,700,000 United States dollar | superseded | [clm_97C821417430](/claim/clm_97C821417430.md)
- 2026-03-31 to 2026-06-30 | total_assets | 1,000,500,000 United States dollar | superseded | [clm_A21F781A12D3](/claim/clm_A21F781A12D3.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | -25,300,000 United States dollar | superseded | [clm_B088629105C6](/claim/clm_B088629105C6.md)
- 2026-04-23 to 2026-07-29 | shares_outstanding | 169,300,000 shares | superseded | [clm_450DB601E571](/claim/clm_450DB601E571.md)
- 2026-05-11 | board_member | Marylou Maco | valid | [clm_3011D16F9E22](/claim/clm_3011D16F9E22.md)
- 2026-05-11 | board_member | Lydia Paterson | valid | [clm_55832A2EAF57](/claim/clm_55832A2EAF57.md)
- 2026-05-11 | board_member | Sohaib Abbasi | valid | [clm_863051613D8B](/claim/clm_863051613D8B.md)
- 2026-05-11 | acquired | Udemy, Inc. | valid | [clm_FB9526522FE1](/claim/clm_FB9526522FE1.md)
- 2026-06-30 | total_assets | 1,947,800,000 United States dollar | valid | [clm_2D076381CF73](/claim/clm_2D076381CF73.md)
- 2026-06-30 | total_equity | 1,167,000,000 United States dollar | valid | [clm_2EFF13AF786C](/claim/clm_2EFF13AF786C.md)
- 2026-06-30 | quarterly_net_income | -80,400,000 United States dollar | valid | [clm_37AD54A9E475](/claim/clm_37AD54A9E475.md)
- 2026-06-30 | cash_and_equivalents | 871,700,000 United States dollar | valid | [clm_6AF3912F2264](/claim/clm_6AF3912F2264.md)
- 2026-06-30 | quarterly_revenue | 298,600,000 United States dollar | valid | [clm_79EBC5A78540](/claim/clm_79EBC5A78540.md)
- 2026-06-30 | quarterly_operating_income | -84,700,000 United States dollar | valid | [clm_C618F99FA49F](/claim/clm_C618F99FA49F.md)
- 2026-06-30 | quarterly_research_and_development | 43,700,000 United States dollar | valid | [clm_F46C2408F451](/claim/clm_F46C2408F451.md)
- 2026-07-06 | restructuring | Workforce reduction plan aligning cost structure after Udemy merger | valid | [clm_2C158F7ACD1C](/claim/clm_2C158F7ACD1C.md)
- 2026-07-29 | shares_outstanding | 264,400,000 shares | valid | [clm_9D2A9439B327](/claim/clm_9D2A9439B327.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.